Future direction for breast cancer treatment
20 Jul 2012
Future direction for breast cancer treatment
The ceRNA Hypothesis and the non-coding revolution in cancer research and therapy
Australia Pancreatic Cancer Genome Initiative
Bevacizumab benefits beyond progression in TML study subgroups
Translational and tailored, but can we afford it?
Translational and tailored, but can we afford it?
Cost efficiency of targeted therapy
Society and money - the cancer conundrum
Translating cancer research to personalised treatment: Can it work?
Highlights of the 22nd EACR meeting and tackling glioblastoma
Adjuvant cetuximab disappoints again in mCRC
The WINTHER study